Many VCs, particularly newer firms, readily admit that 2024 has been a challenging year for raising fresh capital.
Dimension Capital, a two-year-old venture outfit,...
Archon Biosciences, a biotech startup putting AI to work designing novel biomolecules, has just emerged from stealth with an impressive $20 million in...